LLY Weekly Options Trade Plan 2025-04-17

Join our Discord channel for live trading signals and discussions:

LLY Weekly Analysis Summary (2025-04-17)

Below is our integrated analysis based on the multiple reports and the actual options data:

──────────────────────────────

MODEL SUMMARIES

• Grok/xAI Report  – Notes that although the recent price (≈$734.90) has been under pressure on longer‐term charts, very recent 5‑minute indicators (MACD bullish crossover, RSI rising above 50) and strong positive news (Lilly’s new oral weight loss drug) create a moderately bullish setup.  – Observes heavy call open interest around $775–$780 and a max pain of $770, suggesting that a move upward is being priced in.  – Recommends buying the $775 call (premium ≈$0.95), accepting that the premium is a bit higher than the “ideal” $0.30–$0.60 range if the risk/reward remains acceptable.

• Claude/Anthropic Report  – Emphasizes that although multiple longer‑term technicals are bearish, the day’s strong positive drug trial news and improving short‑term momentum (rising MACD on the 5‑minute chart) push the bias into moderately bullish territory.  – Favors a trade around the near‐the‐money calls. Although a $740 call is mentioned, the report acknowledges that its premium ($8.80) is far from our risk/reward requirements.